Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q2 2023 Earnings Call Transcript

Page 4 of 4

Thomas Flaten: Got it. Thanks so much.

Operator: [Operator Instructions] And your next question comes from the line of Raghuram Selvaraju with H.C. Wainwright. Your line is now open.

Dan Barber: Ram, you might be on mute. Bella, why don’t we move on to the next person, if Ram is having technical difficulties?

Operator: All right. [Operator Instructions] Okay and Raghuram Selvaraju, your line is open. All right, I guess we don’t have any other questions at this time. I will now turn the call back over to Dan Barber.

Dan Barber: Thanks, Bella. Thank you all for joining us this morning. We appreciate your time as always. We believe we have shown a Q2 that is in line with our continued view on growing this business. And we look forward to interacting with you again in the future. Have a great day.

Operator: This concludes today’s conference call. Thank you for your participation. You may now disconnect.

Follow Aquestive Therapeutics Inc. (NASDAQ:AQST)

Page 4 of 4